BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1157752)

  • 1. Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat.
    Thompson ER; Baylink DJ; Wergedal JE
    Endocrinology; 1975 Aug; 97(2):283-9. PubMed ID: 1157752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
    Lees RL; Heersche JN
    J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
    Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
    J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
    Lorenzo JA; Raisz LG; Hock JM
    J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular actions of interleukin-11 on bone resorption in vitro.
    Hill PA; Tumber A; Papaioannou S; Meikle MC
    Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption.
    Hall TJ
    Biochem Biophys Res Commun; 1994 Jul; 202(1):456-62. PubMed ID: 8037747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.
    Turner RT; Wakley GK; Hannon KS; Bell NH
    Endocrinology; 1988 Mar; 122(3):1146-50. PubMed ID: 3342747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity.
    Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K
    Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations.
    Ritchie CK; Maercklein PB; Fitzpatrick LA
    Endocrinology; 1994 Sep; 135(3):996-1003. PubMed ID: 8070395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.
    Hattersley G; Chambers TJ
    Endocrinology; 1989 Sep; 125(3):1606-12. PubMed ID: 2547591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of endosteal bone volume.
    Baylink DJ; Liu CC
    J Periodontol; 1979 Apr; 50(4 Spec No):43-9. PubMed ID: 287776
    [No Abstract]   [Full Text] [Related]  

  • 14. Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.
    Sun L; Iqbal J; Dolgilevich S; Yuen T; Wu XB; Moonga BS; Adebanjo OA; Bevis PJ; Lund F; Huang CL; Blair HC; Abe E; Zaidi M
    FASEB J; 2003 Mar; 17(3):369-75. PubMed ID: 12631576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts.
    Schwartz Z; Lohmann CH; Wieland M; Cochran DL; Dean DD; Textor M; Bonewald LF; Boyan BD
    J Periodontol; 2000 Apr; 71(4):586-97. PubMed ID: 10807123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
    Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
    J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones.
    Tobias J; Chambers TJ
    Endocrinology; 1989 Sep; 125(3):1290-5. PubMed ID: 2759026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat.
    Klapisz-Wolikow M; Saffar JL
    J Cell Physiol; 1996 May; 167(2):359-68. PubMed ID: 8613479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.